Crossmark

Comparisons of tumor-infiltrating lymphocyte levels and the 21-gene recurrence score in ER-positive/HER2-negative breast cancer

Crossref DOI link: https://doi.org/10.1186/s12885-018-4228-6

Published Online: 2018-03-24

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ahn, Sung Gwe

Cha, Yoon Jin

Bae, Soon June

Yoon, Chanik

Lee, Hak Woo

Jeong, Joon http://orcid.org/0000-0003-0397-0005
Funding

Funding for this research was provided by:

National Research Foundation of Korea (2015R1C1A1A02037104)

Ministry of Health and Welfare (1520120)
License Information

Text and Data Mining valid from 2018-03-24
More Information

Article History

Received: 20 October 2017

Accepted: 15 March 2018

First Online: 24 March 2018

Ethics approval and consent to participate

: The study protocol was reviewed and approved by the Institutional Review Boards of he Gangnam Severance Hospital, Yonsei University, Seoul, Korea, and adhered to the tenets of the Declaration of Helsinki. Owing to retrospective approach of this study, the need for informed consent was waived by the ethics committees.

: Not applicable.

: The authors declare that they have no competing interest.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.